Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Accenture
Cipla
AstraZeneca
Daiichi Sankyo
Moodys
Boehringer Ingelheim
Fish and Richardson
McKinsey
Dow

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,699,503

« Back to Dashboard

Summary for Patent: 6,699,503

Title: Hydrogel-forming sustained-release preparation
Abstract:The invention provides a hydrogen-type sustained-release preparation comprising (1) at least one drug, (2) an additive which insures a penetration of water into the core of the preparation and (3) a hydrogen-forming polymer, wherein said preparation is capable of undergoing substantially complete gelation during its stay in the upper digestive tract such as stomach and small intestine and is capable of releasing the drug in the lower digestive tract including colon. By the preparation of the invention, the drug is efficiently released and absorbed even in the colon so that a steady and sustained release effect can be achieved.
Inventor(s): Sako; Kazuhiro (Shizuoka, JP), Nakashima; Hiroshi (Shizuoka, JP), Sawada; Toyohiro (Shizuoka, JP), Okada; Akira (Shizuoka, JP), Fukui; Muneo (Shizuoka, JP)
Assignee: Yamanuchi Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:09/702,880
Patent Claim Types:
see list of patent claims
Compound;

No matches for this query

Foreign Priority and PCT Information for Patent: 6,699,503

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan4-274979Sep 18, 1992
Japan5-165263Jun 08, 1993

International Patent Family for Patent: 6,699,503

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria219933► Subscribe
Australia4983893► Subscribe
Australia682827► Subscribe
Bulgaria61861► Subscribe
Bulgaria99503► Subscribe
Canada2144077► Subscribe
China1048397► Subscribe
China1091004► Subscribe
Czech Republic291495► Subscribe
Czech Republic9500679► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Covington
Citi
Fuji
Teva
Daiichi Sankyo
Colorcon
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot